Single DMT Dose Eases Depression for Months in Trial

Imagine battling severe depression for a decade, trying treatment after treatment with no relief, then finding hope in a single 25-minute session.

That's exactly what happened for participants in a groundbreaking trial at Imperial College London. Researchers gave 34 people with long-term, treatment-resistant depression either DMT (a powerful psychedelic) or a placebo, alongside therapy support. The results were remarkable.

Two weeks after receiving DMT, participants saw their depression scores drop by 7.4 points more than the placebo group. Even better, this improvement lasted for three months, with some people feeling the benefits for up to six months.

The study focused on people who had suffered moderate to severe depression for about 10 years and had already tried at least two conventional treatments without success. Half received a single intravenous dose of DMT over 10 minutes while the other half got a placebo infusion.

Researchers found something fascinating about what made the treatment work. The more intensely someone experienced feelings of unity, profound emotional shifts, and changes in how they perceived time and space, the better their recovery tended to be.

Side effects were minimal. Some participants reported temporary anxiety, nausea, or pain at the injection site, but nothing serious or long-lasting.

The Bright Side

What makes this discovery especially promising is its simplicity and efficiency. Unlike other psychedelic treatments using psilocybin or LSD that last hours, DMT's effects are over in 25 minutes. This could dramatically reduce treatment costs and make help more accessible.

Lead researcher David Erritzoe emphasized how safe and well-tolerated the treatment proved to be. The results match what longer-acting psychedelics have shown, but in a fraction of the time.

Scientists believe DMT might work by temporarily opening a window where the brain can form new connections or by reducing inflammation linked to poor mental health. Either way, it's giving people who'd lost hope a real chance at feeling better.

Similar DMT-based treatments are now moving through approval processes, with one modified version likely to receive US approval soon. For millions living with depression that doesn't respond to standard care, this research represents a genuine breakthrough.

One dose, 25 minutes, months of relief: that's the kind of progress worth celebrating.